OLR1 and inflammatory bowel disease: Furthermore, the mechanisms for the anti-inflammatory effect of HUMSCs in inflammatory bowel disease and type 2 diabetes were through the modulation of 15-LOX-1 in macrophages 39 and suppressing NLRP3 inflammasome 17 respectively.